Caribou Biosciences Shares Fall After HC Wainwright Downgrade
MT newswire2026/10/08 19:4003:40 PM EDT, 10/08/2026 (MT Newswires) -- Caribou Biosciences (CRBU) shares fell over 22% in Thursday trading after HC Wainwright downgraded the stock to neutral from buy. Trading volume stood at nearly 18 million shares, compared with a daily average of about 1.9 million. Price: 0.48, Change: -0.14, Percent Change: -22.24
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.


Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF